RPM

109.91

+4.25%↑

CMC

66.14

+3.33%↑

NGR

10.93

+8%↑

FUL

64.35

+3.34%↑

WDFC

213.08

+4.98%↑

RPM

109.91

+4.25%↑

CMC

66.14

+3.33%↑

NGR

10.93

+8%↑

FUL

64.35

+3.34%↑

WDFC

213.08

+4.98%↑

RPM

109.91

+4.25%↑

CMC

66.14

+3.33%↑

NGR

10.93

+8%↑

FUL

64.35

+3.34%↑

WDFC

213.08

+4.98%↑

RPM

109.91

+4.25%↑

CMC

66.14

+3.33%↑

NGR

10.93

+8%↑

FUL

64.35

+3.34%↑

WDFC

213.08

+4.98%↑

RPM

109.91

+4.25%↑

CMC

66.14

+3.33%↑

NGR

10.93

+8%↑

FUL

64.35

+3.34%↑

WDFC

213.08

+4.98%↑

Search

International Flavors & Fragrances Inc

Suletud

SektorToorained

75.78 5.38

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

75.4

Max

76.13

Põhinäitajad

By Trading Economics

Sissetulek

-22M

18M

Müük

-105M

2.6B

Aktsiakasum

0.8

Dividenditootlus

2.21

Kasumimarginaal

0.695

Töötajad

21,500

EBITDA

-43M

308M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+18.87% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

2.21%

2.75%

Järgmine tulemuste avaldamine

5. mai 2026

Järgmine dividendimakse kuupäev

10. juuli 2026

Järgmine aktsia dividendi kuupäev (ex-date)

19. juuni 2026

Turustatistika

By TradingEconomics

Turukapital

-950M

18B

Eelmine avamishind

70.4

Eelmine sulgemishind

75.78

Uudiste sentiment

By Acuity

18%

82%

15 / 150 Pingereas Basic materials

Tehniline skoor

By Trading Central

Kindlus

Strong Bearish Evidence

International Flavors & Fragrances Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

17. apr 2026, 20:26 UTC

Omandamised, ülevõtmised, äriostud

UCB to Buy Neurona Therapeutics for Up to $1.15 Billion

17. apr 2026, 18:15 UTC

Uudisväärsed sündmused

Fed's Waller: Prolonged Iran Conflict Could Block Path to Rate Cuts

17. apr 2026, 16:49 UTC

Uudisväärsed sündmused

Week Ahead for FX, Bonds: U.S. Retail Sales, PMI -2-

18. apr 2026, 01:00 UTC

Uudisväärsed sündmused

As Economic Pressures Mount, Will Iran or the U.S. Blink First? -- WSJ

17. apr 2026, 22:58 UTC

Tulu

Grupo Aeroportuario Del Pacifico: Announces Filing of 2025 Annual Report and Form 20-F

17. apr 2026, 21:32 UTC

Market Talk

Cerebras IPO Adds to Big Year For AI Firms Going Public -- Market Talk

17. apr 2026, 21:22 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17. apr 2026, 21:22 UTC

Market Talk

Moody's Downgrades Belgium to A1 -- Market Talk

17. apr 2026, 20:52 UTC

Tulu

Schwab Investors Get Spooked by JPMorgan's AI Strategy. The Big Worry Is Cash Sweeps. -- Barrons.com

17. apr 2026, 20:50 UTC

Market Talk
Tulu
Omandamised, ülevõtmised, äriostud

Tech, Media & Telecom Roundup: Market Talk

17. apr 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

17. apr 2026, 20:29 UTC

Tulu

These Stocks Are Today's Movers: Royal Caribbean, Dow Inc., Netflix, Intel, Albemarle, Autoliv, Alcoa, and More -- Barrons.com

17. apr 2026, 20:11 UTC

Omandamised, ülevõtmised, äriostud

UCB to Buy Neurona Therapeutics for Up to $1.15B

17. apr 2026, 19:34 UTC

Market Talk
Tulu
Omandamised, ülevõtmised, äriostud

Global Equities Roundup: Market Talk

17. apr 2026, 19:34 UTC

Market Talk
Tulu
Omandamised, ülevõtmised, äriostud

Analysts See Netflix's Deal Commentary as Notable -- Market Talk

17. apr 2026, 19:31 UTC

Market Talk
Uudisväärsed sündmused

Oil Futures Fall on Reopening of Strait of Hormuz -- Market Talk

17. apr 2026, 19:26 UTC

Market Talk

U.S. Natural Gas Futures Edge Up -- Market Talk

17. apr 2026, 19:21 UTC

Market Talk

Albemarle's Outperformance Belies Longer-Term Risks -- Market Talk

17. apr 2026, 19:15 UTC

Market Talk

Danaher Seen Rebounding in 2H After Tools-Sector Weakness -- Market Talk

17. apr 2026, 19:07 UTC

Market Talk

Danaher Faces Tough Comparative but Long‑Term Story Intact -- Market Talk

17. apr 2026, 18:57 UTC

Uudisväärsed sündmused

U.S. Stocks Surge on Hope Iran War Nearing End. Foreign Leaders Have a More Sober View. -- Barrons.com

17. apr 2026, 18:53 UTC

Omandamised, ülevõtmised, äriostud

UCB Expects 2026 Adjusted Ebitda Growth in High Single-Digit to Mid-Teens Percentage Range at Constant Exchange Rates

17. apr 2026, 18:53 UTC

Omandamised, ülevõtmised, äriostud

UCB 2026 Rev Guidance Unchanged

17. apr 2026, 18:52 UTC

Omandamised, ülevõtmised, äriostud

UCB: Neurona Deal to Include $650M Upfront and Up to $500M in Potential Future Milestones

17. apr 2026, 18:52 UTC

Omandamised, ülevõtmised, äriostud

UCB to Acquire Neurona Therapeutics for Up to $1.15B Including Potential Milestones

17. apr 2026, 18:14 UTC

Market Talk
Uudisväärsed sündmused

Precious Metals Close Higher as Stronger Demand Eyed -- Market Talk

17. apr 2026, 18:00 UTC

Uudisväärsed sündmused

Fed's Waller: Quick Resolution in Middle East Could Allow Cuts Later This Year

17. apr 2026, 18:00 UTC

Uudisväärsed sündmused

Fed's Waller: Job Losses May Not Signal Recession Amid Demographic Changes

17. apr 2026, 17:31 UTC

Market Talk
Uudisväärsed sündmused

U.S. Oil Rig Count Down By 1 at 410 -- Market Talk

17. apr 2026, 17:26 UTC

Market Talk
Tulu

Netflix's Ability to Grow Engagement Seen as Up in the Air -- Market Talk

Võrdlus sarnastega

Hinnamuutus

International Flavors & Fragrances Inc Prognoos

Hinnasiht

By TipRanks

18.87% tõus

12 kuu keskmine prognoos

Keskmine 90.2 USD  18.87%

Kõrge 100 USD

Madal 75 USD

Põhineb 12 Wall Streeti analüütiku instrumendi International Flavors & Fragrances Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

12 ratings

10

Osta

2

Hoia

0

Müü

Tehniline skoor

By Trading Central

73.48 / 78.46Toetus ja vastupanu

Lühikene perspektiiv

Strong Bearish Evidence

Keskpikk perspektiiv

Bullish Evidence

Pikk perspektiiv

Strong Bearish Evidence

Sentiment

By Acuity

15 / 150 Pingereas Toorained

Uudiste sentiment

Väga tugevad tõusu märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest International Flavors & Fragrances Inc

International Flavors & Fragrances Inc., together with its subsidiaries, manufactures and sells cosmetic active and natural health ingredients for use in various consumer products in the United States, Europe, and internationally. It operates through four segments: Nourish, Health & Biosciences, Scent, and Pharma Solutions. The Nourish segment offers natural and plant-based specialty food ingredients, such as flavor compounds used in savory products; beverages; sweets; and dairy products. It also provides value-added spices and seasoning ingredients; savory solutions, including spices, sauces, marinades, and mixtures; and natural antioxidants and anti-microbials. The Health & Biosciences segment develops and produces enzymes, food cultures, probiotics, and specialty ingredients for food and non-food applications. Its Scent segment provides fragrance compounds, which include fine fragrances comprising perfumes and colognes, as well as consumer fragrances; fragrance ingredients comprising synthetic and natural ingredients that include natural flavor extracts, specialty botanical extracts, distillates, essential oils, citrus products, aroma chemicals, natural gums, and resins; and cosmetic active ingredients consisting of active and functional ingredients, and delivery systems for cosmetic and personal care product industries. Its Pharma Solutions segment produces and sells cellulosics and seaweed-based pharma excipients. The company sells its products primarily to manufacturers of perfumes and cosmetics, hair and other personal care products, soaps and detergents, cleaning products, dairy, meat and other processed foods, beverages, snacks and savory foods, sweet and baked goods, dietary supplements, infant and elderly nutrition, functional food, and pharmaceutical excipients and oral care products. International Flavors & Fragrances Inc. was incorporated in 1909 and is headquartered in New York, New York.
help-icon Live chat